| Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: a multi-country study MF Janssen, AS Pickard, D Golicki, C Gudex, M Niewada, L Scalone, ... Quality of life research 22, 1717-1727, 2013 | 1521 | 2013 |
| Influence of gender on baseline features and clinical outcomes among 17,370 patients with confirmed ischaemic stroke in the international stroke trial M Niewada, A Kobayashi, PAG Sandercock, B Kamiński, A Członkowska Neuroepidemiology 24 (3), 123-128, 2005 | 338 | 2005 |
| Validity of EQ-5D-5L in stroke D Golicki, M Niewada, J Buczek, A Karlińska, A Kobayashi, MF Janssen, ... Quality of life research 24, 845-850, 2015 | 239 | 2015 |
| Comparing responsiveness of the EQ-5D-5L, EQ-5D-3L and EQ VAS in stroke patients D Golicki, M Niewada, A Karlińska, J Buczek, A Kobayashi, MF Janssen, ... Quality of Life Research 24, 1555-1563, 2015 | 148 | 2015 |
| Valuation of EQ‐5D Health States in Poland: First TTO‐Based Social Value Set in Central and Eastern Europe D Golicki, M Jakubczyk, M Niewada, W Wrona, JJV Busschbach Value in Health 13 (2), 289-297, 2010 | 134 | 2010 |
| EQ-5D-5L Polish population norms D Golicki, M Niewada Archives of Medical Science 13 (1), 191-200, 2017 | 111 | 2017 |
| Health technology assessment in Poland, the Czech Republic, Hungary, Romania and Bulgaria L Gulácsi, AM Rotar, M Niewada, O Löblová, F Rencz, G Petrova, I Boncz, ... The European journal of health economics 15, 13-25, 2014 | 111 | 2014 |
| The international stroke trial database PAG Sandercock, M Niewada, A Członkowska, ... Trials 12 (1), 101, 2011 | 85 | 2011 |
| Modafinil for narcolepsy: systematic review and meta-analysis D Golicki, M Bała, M Niewada, A Wierzbicka Medical science monitor 16 (8), 2010 | 82 | 2010 |
| Valuation of EQ-5D-5L health states in Poland: the first EQ-VT-based study in Central and Eastern Europe D Golicki, M Jakubczyk, K Graczyk, M Niewada Pharmacoeconomics 37, 1165-1176, 2019 | 79 | 2019 |
| Acute ischemic stroke care and outcome in centers participating in the Polish National Stroke Prevention and Treatment Registry M Niewada, M Skowronska, D Ryglewicz, B Kamiński, A Członkowska Stroke 37 (7), 1837-1843, 2006 | 73 | 2006 |
| Lifestyle modification for stroke prevention: facts and fiction M Niewada, P Michel Current opinion in neurology 29 (1), 9-13, 2016 | 62 | 2016 |
| General population reference values for 3-level EQ-5D (EQ-5D-3L) questionnaire in Poland D Golicki, M Niewada Pol Arch Med Wewn 125 (1-2), 18-26, 2015 | 60 | 2015 |
| Self-assessed health status in Poland: EQ-5D findings from the Polish valuation study D Golicki, M Niewada, M Jakubczyk, W Wrona, T Hermanowski Pol Arch Med Wewn 120 (7-8), 276-81, 2010 | 60 | 2010 |
| Use of biologics for psoriasis in Central and Eastern European countries F Rencz, L Kemény, JZ Gajdácsi, W Owczarek, P Arenberger, GS Tiplica, ... Journal of the European Academy of Dermatology and Venereology 29 (11), 2222 …, 2015 | 58 | 2015 |
| Leflunomide in monotherapy of rheumatoid arthritis: meta-analysis of randomized trials D Golicki, M Niewada, J Lis, K Pol, T Hermanowski, M Tlustochowicz Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews …, 2012 | 56 | 2012 |
| A multinational, multi‐centre, observational, cross‐sectional survey assessing diabetes secondary care in Central and Eastern Europe (DEPAC Survey) M Andel, W Grzeszczak, J Michalek, M Medvescek, A Norkus, I Rasa, ... Diabetic medicine 25 (10), 1195-1203, 2008 | 56 | 2008 |
| Persistence with treatment for Wilson disease: a retrospective study W Masełbas, A Członkowska, T Litwin, M Niewada BMC neurology 19, 1-6, 2019 | 49 | 2019 |
| Wytyczne postępowania w udarze mózgu B Błażejewska-Hyżorek, A Czernuszenko, A Członkowska, A Ferens, ... Polski Przegląd Neurologiczny 15 (A), 1-156, 2019 | 47 | 2019 |
| Sex differences in risk factor distribution, severity, and outcome of ischemic stroke M Wiszniewska, M Niewada, A Czlonkowska Acta Clinica Croatica 50 (1), 21-28, 2011 | 44 | 2011 |
